Advisor Group Holdings, Inc. Applied Genetic Technologies Corp Transaction History

Advisor Group Holdings, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.29 - $0.89 $57 - $178	-200 Reduced 12.5%	1,400 $0
Q2 2022 Aug 10, 2022	BUY	$0.62 - $1.1 $744 - $1,320	1,200 Added 300.0%	1,600 $1,000
Q1 2022 May 04, 2022	SELL	$1.07 - $2.71 $535 - $1,355	-500 Reduced 55.56%	400 $24,000
Q3 2021 Nov 05, 2021	SELL	$3.01 - $4.12 $27,390 - $37,492	-9,100 Reduced 91.0%	900 $3,000
Q1 2020 May 18, 2020	BUY	$2.36 - $9.86 $23,600 - $98,600	10,000 New	10,000 $33,000

Ticker AGTC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,632,200
Description
Applied Genetic Technologies Corporation, a clinical-stage biotechnology company, develops transformational genetic therapies for patients suffering from rare and debilitating diseases. Its advanced product candidates include three ophthalmology development programs across two targets, including X-linked retinitis pigmentosa, which is in the Pha...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.